Fly over Australia’s outback, visit a midwife in Ethiopia and learn about how we can make life-changing biologic medicines accessible for more patients - in the new issue of ‘Making Access Happen - For better healthcare around the world’
Lord Jim O’Neill, the author of the UK government-commissioned Review on AMR, has called on the pharmaceutical industry to “think more broadly” about the role it can play in combatting the growing global threat of antimicrobial resistance (AMR).
Since the early 2000s, according to the World Health Organization, some 6.3 million malaria deaths have been prevented. This is the result of broad educational programs, the use of insect-repellant nets and active improvements in access to artemisinin-based treatment. Still, more than 400,000 people die each year of malaria. To save even more lives, UN Senior Advisor Alan Court recommends reducing inefficiencies through public-private partnerships.
Sheila Frame, VP and Head of Biopharmaceuticals in North America, reflects on the newly published RAND report highlighting the potential USD 54 billion in cost savings offered by the expansion of biosimilars in the US.
Soap and water can save lives. Every day, by washing their hands properly, people can prevent the spread of diseases and infections. In hospitals, good hand hygiene slows the spread of resistant bacteria. We examine some of the health effects of handwashing.
In Australia’s sparsely populated outback, the next hospital might be hours or even days away by road. This could put a patient’s life in danger. For nearly a century, the Royal Flying Doctor Service has been bringing medical access to patients, and improving health services in remote areas.
Novartis was ranked 4th in Fortune magazine’s Change the World list and cited for developing an innovative new cancer treatment, working to expand access to healthcare and supporting value-based pricing.
This site is intended for a global audience